These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 37944618

  • 1. Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors.
    Madsen JJ, Petersen JE, Christensen DP, Hansen JB, Schwartz TW, Frimurer TM, Olsen OH.
    J Biol Chem; 2023 Dec; 299(12):105438. PubMed ID: 37944618
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
    Gether U, Johansen TE, Schwartz TW.
    J Biol Chem; 1993 Apr 15; 268(11):7893-8. PubMed ID: 7681831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of both NK1 and NK2 receptors in guinea-pig airways.
    McKee KT, Millar L, Rodger IW, Metters KM.
    Br J Pharmacol; 1993 Oct 15; 110(2):693-700. PubMed ID: 7694756
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA, Patacchini R, Meini S, Quartara L, Sisto A, Potier E, Giuliani S, Giachetti A.
    Br J Pharmacol; 1994 May 15; 112(1):150-60. PubMed ID: 7518302
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M, Improta G, Tabacco A.
    Eur J Pharmacol; 1999 Jul 02; 376(1-2):67-71. PubMed ID: 10440091
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor.
    Nederpelt I, Bleeker D, Tuijt B, IJzerman AP, Heitman LH.
    Biochem Pharmacol; 2016 Oct 15; 118():88-95. PubMed ID: 27501920
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tachykinins in the gut. Part I. Expression, release and motor function.
    Holzer P, Holzer-Petsche U.
    Pharmacol Ther; 1997 Oct 15; 73(3):173-217. PubMed ID: 9175155
    [Abstract] [Full Text] [Related]

  • 18. In vitro pharmacological evaluation of the radiolabeled C-terminal substance P analogue Lys-Phe-Phe-Gly-Leu-Met-NH2: Does a specific binding site exist?
    Tomczyszyn A, Csibrany B, Keresztes A, Mallareddy JR, Dyniewicz J, Misicka A, Toth G, Lipkowski AW.
    Folia Neuropathol; 2014 Oct 15; 52(4):383-9. PubMed ID: 25574743
    [Abstract] [Full Text] [Related]

  • 19. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
    Kemel ML, Pérez S, Beaujouan JC, Jabourian M, Soubrié P, Glowinski J.
    J Neurochem; 2003 Oct 15; 87(2):487-96. PubMed ID: 14511126
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.